Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Neuropeptide signaling through neurokinin-1 and neurokinin-2 receptors augments antigen presentation by human dendritic cells.
J Allergy Clin Immunol. 2015 Dec;136(6):1690-1694. doi: 10.1016/j.jaci.2015.06.050. Epub 2015 Sep 12.
J Allergy Clin Immunol. 2015.
PMID: 26371842
Free article.
No abstract available.
IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4(+) T cells.
Ohno Y, Kitamura H, Takahashi N, Ohtake J, Kaneumi S, Sumida K, Homma S, Kawamura H, Minagawa N, Shibasaki S, Taketomi A.
Ohno Y, et al. Among authors: kaneumi s.
Cancer Immunol Immunother. 2016 Feb;65(2):193-204. doi: 10.1007/s00262-015-1791-4. Epub 2016 Jan 12.
Cancer Immunol Immunother. 2016.
PMID: 26759006
Free PMC article.
Item in Clipboard
Lack of interleukin-6 in the tumor microenvironment augments type-1 immunity and increases the efficacy of cancer immunotherapy.
Ohno Y, Toyoshima Y, Yurino H, Monma N, Xiang H, Sumida K, Kaneumi S, Terada S, Hashimoto S, Ikeo K, Homma S, Kawamura H, Takahashi N, Taketomi A, Kitamura H.
Ohno Y, et al. Among authors: kaneumi s.
Cancer Sci. 2017 Oct;108(10):1959-1966. doi: 10.1111/cas.13330. Epub 2017 Aug 29.
Cancer Sci. 2017.
PMID: 28746799
Free PMC article.
Item in Clipboard
IL-11 induces differentiation of myeloid-derived suppressor cells through activation of STAT3 signalling pathway.
Sumida K, Ohno Y, Ohtake J, Kaneumi S, Kishikawa T, Takahashi N, Taketomi A, Kitamura H.
Sumida K, et al. Among authors: kaneumi s.
Sci Rep. 2015 Sep 1;5:13650. doi: 10.1038/srep13650.
Sci Rep. 2015.
PMID: 28781374
Free PMC article.
Item in Clipboard
Ecrg4 contributes to the anti-glioma immunosurveillance through type-I interferon signaling.
Moriguchi T, Kaneumi S, Takeda S, Enomoto K, Mishra SK, Miki T, Koshimizu U, Kitamura H, Kondo T.
Moriguchi T, et al. Among authors: kaneumi s.
Oncoimmunology. 2016 Oct 14;5(12):e1242547. doi: 10.1080/2162402X.2016.1242547. eCollection 2016.
Oncoimmunology. 2016.
PMID: 28123880
Free PMC article.
Item in Clipboard
Cite
Cite